• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 202

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2022 Jun 10;ciac469.
doi: 10.1093/cid/ciac469. Online ahead of print.
Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021


Maureen J Miller[SUP] 1 [/SUP], Austin Himschoot[SUP] 2 [/SUP], Natalie Fitch[SUP] 2 [/SUP], Sucheta Jawalkar[SUP] 2 [/SUP], Dane Freeman[SUP] 2 [/SUP], Charity Hilton[SUP] 2 [/SUP], Kevin Berney[SUP] 3 [/SUP], Gery P Guy[SUP] 1 [/SUP], Tina J Benoit[SUP] 1 [/SUP], Kristie E N Clarke[SUP] 1 [/SUP], Michael P Busch[SUP] 4 [/SUP], Jean D Opsomer[SUP] 5 [/SUP], Susan L Stramer[SUP] 6 [/SUP], Aron J Hall[SUP] 1 [/SUP], Adi V Gundlapalli[SUP] 1 [/SUP], Adam MacNeil[SUP] 1 [/SUP], Russell McCord[SUP] 1 [/SUP], Gregory Sunshine[SUP] 1 [/SUP], Mara Howard-Williams[SUP] 1 [/SUP], Christopher Dunphy[SUP] 1 [/SUP], Jefferson M Jones[SUP] 1 [/SUP]



Affiliations

Abstract

Objectives: To assess if state-issued nonpharmaceutical interventions (NPIs) are associated with reduced rates of SARS-CoV-2 infection as measured through anti-nucleocapsid (anti-N) seroprevalence, a proxy for cumulative prior infection that distinguishes seropositivity from vaccination).
Methods: Monthly anti-N seroprevalence during August 1, 2020 - March 30, 2021 was estimated using a nationwide blood donor serosurvey. Using multivariable logistic regression models, we measured the association of seropositivity and state-issued, county-specific NPIs for mask mandates, gathering bans, and bar closures.
Results: Compared with individuals living in a county with all three NPIs in place, the odds of having anti-N antibodies were 2.2 (95% CI: 2.0-2.3) times higher for people living in a county that did not have any of the three NPIs, 1.6 (95% CI: 1.5-1.7) times higher for people living in a county that only had a mask mandate and gathering ban policy, and 1.4 (95% CI: 1.3-1.5) times higher for people living in a county that had only a mask mandate.
Conclusions: Consistent with studies assessing NPIs relative to COVID-19 incidence and mortality, the presence of NPIs were associated with lower SARS-CoV-2 seroprevalence indicating lower rates of cumulative infections. Multiple NPIs are likely more effective than single NPIs.

Keywords: COVID-19; SARS-CoV-2; nonpharmaceutical interventions; novel coronavirus; seroprevalence.
 
Back
Top Bottom